Institutional investors purchased a net $387.3 thousand shares of THOR during the quarter ended June 2015 and now own 94.97% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 826.5 Thousand shares of Thoratec Corp
EAGLE ASSET MANAGEMENT, INC. Bought 590.7 Thousand shares of Thoratec Corp
PARK WEST ASSET MANAGEMENT LLC Bought 372.3 Thousand shares of Thoratec Corp